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Effects of captopril administration on blood pressure, protelnuria and
kidney function in patients with diabetic nephropathy. N. Koçak, S.
Bozfakiolu, M.$. Sever, S.T. Ecder, N. Aysuna, E. Ozdogan, . Tuna,
E. Ark, Istanbul Medical Faculty, Department ofNephrology, Istan-
bul, Turkey. Effects of captopril administration on blood pressure,
proteinuria and kidney functions in uremic patients due to diabetic
nephropathy were investigated for 5 days. Twelve patients with type I
(6 patients) and type 11(6 patients) diabetes mellitus were analyzed. The
drug, at a dose of 100 mg/day, reduced arterial blood pressure signifi-
cantly. Plasma renin activity and aldosterone levels were found to be
decreased after converting enzyme inhibition. Urinary Na and K
excretion decreased in 6 and 5 patients, respectively. The daily excre-
tion of Na was not stable in S patients and K in 6 patients throughout the
study. Only one patient's daily Na and K excretion increased after
captopril administration. Urinary protein excretion decreased in all of
the patients. Creatinine clearance reduced significantly. Seven healthy
volunteers were taken as control cases. Five days after captopril
administration at the same dose, arterial blood pressure decreased less
significantly. Plasma renin activity and aldosterone levels increased in
control cases. Urinary Na excretion increased in 5 cases and did not
show stable levels in 2 cases, whereas urinary K excretion increased in
3 cases and showed variation in 4 cases. In one of the control cases,
trace proteinuria that lasted for 3 days was noted. No significant change
was observed in creatinine clearance. In conclusion, the increase of
aldosterone levels after converting enzyme inhibition with captopril in
control cases was explained on the basis of direct stimulation of
aldosterone release from adrenal glands, but the cause of the reduction
in plasma renin activity in diabetic patients remained obscure. On the
other hand, it was postulated that there might be a direct effect of the
drug on renal tubular cells because of the changes observed in urinary
Na and K excretion. The decrease of proteinuria in diabetic patients
might also be explained by the lowering of both systemic and glomer-
ular hypertension due to captopnl's effect.
Recombinant human erythropoietin (rfluEpo) treatment in predialysis
patients. M: Ayaz, R. Ataman, S. Dalmak, K. Serdengeçti, U. UI/cu, E.
Erek, K. Onen, Cerrahpaa Tip Fakultesi, Ic Hasialikiari Anabilim
Dali, Nefroloji Bilim Dali, Seven patients with end-stage chronic renal
failure (plasma creatinin 5.7 to 14.8 mg%) with an age range of 20 to 58;
S female, 2 male were treated with subcutaneous erythropoietin.
Starting dose was thrice weekly 50 ia/kg and therapy was continued with
25 iJkg for 16 weeks. In all patients hemoglobin values were less than
9 g%. All but one patient received iron supplementation. Hemoglobin
levels rose from 6.88 to 10.3 g% (P < 0.01), red blood cell count from
2.86 x 10 to 3.57 x 10 mm (P < 0.01), hematocrit from 22% to 34% (P
<0.005), Iron binding capacity from 254 to 319 gama % (P < 0.0125)
and albumin from 3.89 to 4.26 g% (P < 0.0125). The other parameters
measured (WUC, platelets, iron urea, creatinine inorganic phosphorus,
calcium) showed no significant changes. Hypertension was observed in
two patients but could be controlled by increasing antihypertensive
treatment. One av-fistula occluded but we decided that it was most
probably not due to rHuEpo, but to failure of fistula development. In
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conclusion, we decided rHuEpo to be a safe treatment in end-stage
renal failure patients.
Hepatitis B infection and other hepatitis in renal transplantation. A.
Sonsuz, R. Ataman, S: Dalmak, M. Ayaz, K. Serdengecti, E. Erek, U.
Ulkü, M. Sariyar, K. Onen, Cerrahpaa Medical Faculty, Nephrology,
Hepatology, Transplantation Departments. The effect of renal trans-
plantation on Hepatitis B infection and on other hepatic diseases has
been investigated in 62 patients. Patients were divided into four groups
according to the presence of HBsAg and to the serum levels ALT:
A: HBsAg (+), ALT (Normal)
B: HBsAg (+), ALT (High)a
C: HBsAg (-), ALT (High)a
D: HBsAg (-), ALT (Normal)
a Serum ALT levels were 1.5 times the upper normal value in at least
two blood samples taken monthly.
The status of these patients in the pre
described in the table:
and post-transplant period is
A
Pretransplant
Posttransplant
A B C D
6 3 3 —
B — — — — —
C 2 — — 1 1
D 54 2 4 12 36
Total 62 5 7 13 37
In liver biopsies performed after renal transplantation; chronic active
hepatitis was found in one patient in group A(l/l), in five patients in
group B(5/7), in one patient in group C(l/2), one patient in group D(l/3)
while chronic persistent hepatitis was observed in one patient in group
B(l/7), in two patients in group D(2/3). Fatty liver in one patient in
group B(l/7) and severe coagulation necrosis in one patient in group
C(1/2) were observed. In conclusion, it was found that in the posttrans-
plant period, patients were under high risk of hepatitis B virus infection
(6/54; 11%) and other hepatic diseases, not due to hepatitis B virus
infection: (12/50; 24%). We also observed severe histologic lesions such
as chronic active hepatitis which was not significantly different (P <
0.05) between the HBsAg (+) and HBsAg (—) groups.
Renal histopathologlcal findings in 81 patients with nephrotic syn-
drome. M. Güllülü, K. Tinaztepe, M. Yurtkuran, K. Dilek, M. Yavuz,
0. Era!, Uluda&5 University Medical Faculty, Departments of Nephrol-
ogy and Pathology, Bursa, and Hacettepe University Medical Faculty,
Department of Pediatrics, Ankara, Turkey. Eighty-one patients with
nephrotic syndrome who were hospitalized in the U,U.T.F. Nephrol-
ogy Department between 1985 and 1990 were evaluated clinically, in the
laboratory and histopathologically. In our cases mean age was 33.6
15, mean proteinuria was 6.1 3.3 g/day, mean serum protein was 5.3
1.2 g/dl, mean serum albumin was 2.2 0.9 g/dl, mean serum
cholesterol level was 308 75 mgldl, and mean creatinine clearance
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was 65.9 25.8 mI/mm. In the renal histopathological examination of
our cases renal amyloidosis was found in 27 (33%), membranous
glomerulonephritis in 15 (18.5%), membranoproliferative glomerulone-
phritis in 9 (9.8%), end-stage glomerulonephritis in 7 (18.5%), minimal
change nephropathy in 5 (6.1%), focal segmental glomerulosclerosis in
5 (6.1%), mesangial proliferative glomerulonephritis in 4 (4.9%), sys-
temic lupus-associated proliferative glomerulonephritis in 4 (4.9%),
rapidly progressive crescentic glomerulonephritis in 3 (3.7%), and focal
segmental proliferative glomerulonephritis was established in 2 cases
(2.4%).
Relapse therapy using low dose prednisolone in children with nephrotic
syndrome. L. Sever, S. calikan, H. Apak, N. Arisoy, I. U. Cerrahpaf a
Tip Fakdltesi cocuk Sagligi ye Hastalikiari Anabilim Dali, Turkey. Side
effects related to steroid therapy are common in children with nephrotic
syndrome, so all of the therapeutic regimens aim to use the minimal
effective dose during the treatment. A prospective trial was conducted
in order to investigate whether remission could be induced with half of
the standard dose of prednisolone for relapse therapy and to determine
the duration of the remission with this drug regimen. Ten patients (3
girls and 7 boys with ages between 3 to 8 years) with a relapse of
idiopathic nephrotic syndrome were entered into the study. All of these
patients responded to prednisolone during the initial therapy. None of
them was a frequent relapser. Prednisolone was administered at a dose
of 1 mg/kg per 24 hr for the first 4 weeks, followed by a second 4 week
course of alternate day prednisolone at a dose of 1 mg/kg per 48 hr. The
results of this low dose regimen were compared to the results of the
standard steroid therapy (2 mg/kg/day) used in previous or following
relapses in the same patients. During the low dose regimen, the patients
all responded to the therapy, 6 to 26 (mean SD: 12.6 5.9) days after
the treatment. The remission lasted 3 to 12 (mean SD: 6.1 2.7)
months. In the standard therapy regimen the duration for the response
was 5 to 19 (mean SD: 10.8 4.1) days and the duration of the
remissions was at least 3 months. The longest time period for remission
could not be determined because of the ongoing trial. There was no
statistically significant difference between the 2 regimens considering
the time period for the response, but the remission period was signifi-
cantly longer in the standard therapy regimen. It was assumed that all
of the patients had relapses by March 1991, the date on which statistical
measurements were performed. In conclusion, we think that low dose
steroid therapy can cause a short remission period and possibly will not
decrease the total steroid dose which a patient receives throughout the
course of the disease period.
Comparison of the renal effects of calcium channel blockers with
captopril. Z. Eren, M. Ipek Cingi, A. Elbai, S. Uslu, M. Erden, K.
Setenay Dincer, Z. Kaygisiz, K. Ozdamar, Anatolia University, Med-
ical Faculty, Eskifehir, Turkey. We aimed to study the acute and
chronic renal effects of calcium channel blockers (CCBs) and an
angiotensin converting enzyme inhibitor, captopril (C), in rats. In the
study 40 rats were used. They were housed in groups in metabolic cages
and were allowed free access to tap water. Nitrendipin (2.4 mg/kg),
nifedipin (1.2 mg/kg), verapamil (6 mg/kg) and captopril (1 mg/kg) were
given i.p. once a day. Urine was collected to find out acute and chronic
effects during 2nd, 4th, 24th hours and 2nd, 3rd, 8th days. Urine
volumes were determined and we analyzed urea, creatinine, P3, Ca2,
uric acid, Na, K levels. Blood samples were investigated for BUN,
creatinine, P3, Ca2, uric acid, Na, and K levels. The natriuretic
and diuretic effects of CCBs were found to be statistically higher in the
control and captopril groups (P < 0.001). Creatinine clearance values of
the drugs were similar to controls.
Immune and genetic disorders in the pathogenesis of steroid-responsive
nephrotic syndrome. S. Mir, A. Cura, N. Kutukcfller, K. Kavakli,
E.U.T.F. Pediatrik Nefroloji Bilim Dali, Bornova, IZMIR, Turkey.
Most children with nephrotic syndrome have an idiopathic steroid-
responsive form of disease (SRNS). Although the pathogenesis of
SRNS is obscure, involvement of an immune mechanism is often
suggested, because of remission after immunomodulating therapy,
abnormalities of immunoglobulin class and association with lympho-
kines. Our study consisted of 30 patients with SRNS. In order to
elucidate a possible genetic defect, we also analyzed class I and class II
MHC antigens in the families of 10 of our patients; 30 cases of control
group who were healthy individuals and had no history of nephrotic
syndrome were also studied. Investigation of patients was done during
the active disease period. We have studied the phenotypic frequency of
antigens for HLA-A, -B, -C, -DR as well as total T and B lymphocytes,
and the lymphocyte subsets (CD4 and CD8 and their ratio) HLA
antigens were determined by standard lymphocytotoxicity assay and
lymphocyte subsets were analyzed by monoclonal antibodies in an
immunofluorescence microscope. HLA-DR7, HAL-Bw73 with relative
risks higher than 4.0 showed the strongest association with SRNS. No
common haplotype was found in SRNS patients in whom complete
family studies were done. In the studies for cellular immune disorder,
total B lymphocytes were normal, but total T lymphocytes and sup-
pressor T cells decreased and CD4/CD8 ratio was higher than normal.
In conclusion, we have decided that a pathogenetic relationship be-
tween MHC, cellular immune system and SRNS may be elucidated by
our future studies with a larger series of patients.
Treatment of tumor lysis syndrome in B cell ALL using continuous
arteriovenous hemodiaflitration. L. Saglamer, H. Oz, S. calikan, A.
Ekinci, L. Sever, L. Ulukutlu, I. Yildiz, B. Aykac, Department of
Pediatrics and Intensive Care, Cerrahpaa Medical School of Istanbul
University, Istanbul, Turkey. The metabolic components of tumor lysis
syndrome, consisting of hyperuricemia, hyperkalemia, hyperphos-
phatemia and hypocalcemia, are particularly severe in children with
advanced stage Burkitt lymphoma and B cell leukemia, as a conse-
quence of rapid cell proliferation and rapid response to chemotherapy.
It can also occur before treatment starts and becomes life threatening if
renal failure develops. Continuous arteriovenous hemofiltration
(CAVH) is a safe and effective therapy of acute renal failure in critically
ill patients, and with continuous arteriovenous hemodiafiltration
(CAVHD), higher solute clearances can be achieved. We have used
CAVHD in the treatment of tumor lysis syndrome and renal failure
occurring before chemotherapy and report our experience. A 12-year-
old boy presented with a 10-day history of pallor, lethargy, vomiting,
abdominal pain and purpura. He was found to have 6 cm hepatomegaly,
3 cm splenomegaly and hematuria. B cell ALL was diagnosed with Hb
5.4 g/dl, WBC count 25.0 x l09/liter, platelet count 30,000/mm3, 59%
L3-lymphoblasts in peripheral blood and 86% L3-lymphoblasts (surface
immunoglobulin positive) in the bone marrow. Initial laboratory values
were LDH 4500 U/liter, uric acid 21.5 mg/dl, urea 303 mg/dl, creatinine
6.7 mg/dl, Na 128 mEq/liter, K 6.6 mEq/liter and Ca 5.2 mg/dl. In spite
of a urine output over 2 mI/kg/hr with intravenous fluids at 3 liter/m2/day
with alkalinization, diuretics and allopurinal, the metabolic derange-
ments persisted and the patient became somnolant. It was decided to
institute CAVHD. The cannulae were inserted into the left femoral
artery and vein and a Hemospal-69-S filter was connected. The patient
regained consciousness 4 hours after the start of hemodiafiltration and
urea was 43 mg/dl, creatinine was I mg/dl and uric acid was 9 mg/dl at
10 hours. Chemotherapy was started with prednisone and cyclophos-
phamide with no subsequent problems and CAVHD was ended on the
second day with CAVH being maintained until the 90th hour. The
patient was supported with erythrocyte and platelet transfusions and
responded well to cytotoxic treatment. Now he is in remission with
continuing chemotherapy and has normal renal function. It has been
noted that CAVHD is a safe and, effective method of treatment in
children with tumor lysis syndrome not responding to conservative
measures.
The cadaver kidney recipient pool of the medical faculty of Istanbul:
The demographic analysis of 711 cases. M. ükrü Sever, M. carin, U.
Eldegez, S. Bozfakioglu, N. Aysuna, S. TevfikEcder, M. Unlubozkurt,
R. Ataman, F. Karakullukcu, N. Sarsmaz, A. OzgOziAkara, A. Telaferli,
K. Onen, N. Kocak, The Medical Faculty of Istanbul, The Medical
Faculty of Cerrahpaa, SSK Istanbul Hospital, SSK Göztepe Hospital,
Turk Böbrek Vakfi Dialysis Center, Ren-Med Dialysis Center, Turkey.
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In the Medical Faculty of Istanbul, the kidney transplantation program
from cadaver donors began in 1987, and the formation of a cadaver
kidney recipient pool was started at that time. The number of the
patients examined for clinical and laboratory investigations has reached
711 by March of 1991. A total of 432 of the cases (60.7%) were men and
279 (39.2%) were women, the ages ranging between 9 and 65 (mean
SD: 36.9 12.0). Four hundred and ninety-eight of the patients were
from the dialysis units of Istanbul, while 213 of them were from other
cities. Among these cities, Ankara took the first place with 109 patients;
this was followed by the Turkish Republic of Northern Cyprus with 18
patients. The possible causes of the end-stage renal disease were
chronic glomerulonephritis in 294 cases (41.3%), chronic pyelonephritis
in 130 cases (18.2%), polycystic kidney disease in 25 cases (3.5%),
primary nephrosclerosis in 16 cases (2.2%), amyloidosis in 11 cases
(1.5%), diabetic nephropathy in 9 cases (1.2%) and various other causes
in 20 cases (2.8%). No cause was found in 206 cases (28.9%). The time
that had passed during the hemodialysis therapies ranged between 1 and
144 months (mean SD: 28.2 25.5 months). The patients' rest urine
volume ranged between 0 and 3500 cc when they were first examined
(mean SD: 478.1 642.6 cc). Thirteen of the patients had not yet
begun dialysis therapy and 2 patients were on continuous peritoneal
dialysis therapy. Of the 633 patients, 51(8.0%), 294 (45.8%) and 288
(45.4%) cases had dialysis therapy once, twice and thrice a week,
respectively. It was impossible to get reliable information about the
frequency of dialysis therapies in 63 patients. Hepatitis B surface
antigen was (+) in 36 of the 381 cases (9.4%), white it was (—) in 345 of
them (90.5%). In 330 cases, no information was available about the
HBsAg status. Renal transplantation was previously performed once in
59 cases and twice in 3 cases. Since these patients lost their kidneys as
a result of various complications, they wanted to be candidates for
retransplantation. Of the 711 cases included in the cadaver kidney
waiting list, 103 cases had cadaver kidney transplantation at the
Transplantation Unit of the Medical Faculty of Istanbul.
Influence of erythropoietin treatment on some hormones in hemodia-
lyzed patients. K. Dilek, M. Yurtkuran, M. Guhlu, M. Yavuz, Uludaj
University Medical Faculty, Bursa, Turkey. In 10 female and 9 male
hemodialyzed patients prolactin, PTH, total and free testosterone levels
were followed during 9 months of erythropoietin EPO therapy. Serum
prolactin values decreased significantly in both sexes (P C 0.05) EPO
treatment did not influence significantly PTH, total and free testoster-
one levels (F> 0.5). Conclusion: The improvement in sexual function
under EPO treatment may be related to significantly lowering the levels
of prolactin.
The relationship between the pathogenesis of Henoch-Schonlein vascu-
11th and immunogenetic disorders. N. Kutukçfller, M. coker, S. Mir, A.
Cura, K U. T.F. Pediatrik Nefroloji Bilim Dali, Bornova, Izmir, Turkey.
Henoch-Schonlein vasculitis (HSV) is characterized by small vessel
damage by deposits of immune complexes. In recent studies, higher
levels of serum IgA and B lymphocytes expressing surface IgA mole-
cules were detetmined. Immune complexes with IgA and C3 are also
often detected on the walls of small vessels. In this study we wanted to
elucidate the humoral and cellular immune disorder and genetic linkage
in the pathogenesis of HSV. Our study consisted of 60 cases with 15
HSV patients and 45 cases of their families. Thirty cases of control
group who were healthy individuals and had no history of vasculitis
were also studied. The investigations of the HSV patients were done
during active disease period. We have studied the total T lymphocytes
and their subsets (CD4, CD8) by monocional antibodies in immunoflu-
oresence microscope and the phenotypic frequency of HLA-A, -B, -C,
-DR by standard microlymphocytotoxicity assay. We have also exam-
ined the haplotypes if there was a common one. HLA-B35, HLA-A9,
HLA-A3, with relative risks higher than the others, showed the
strongest association with HSV. In the studies for lymphocyte subsets,
the total T cells and CD8 cells decreased and T helper/T supressor ratio
was higher than the normal. In conclusion, there might be an immuno-
genetic susceptibility for HSV. Larger series of patients have to be
studied to determine further evidence of an immune basis for this
disorder.
A case of acute renal failure associated wIth ovarian carcinoma. M. Y.
Tdlbek, Y.Z. Yergok, M. Gultepe, F. Ucmakli, GATA Haydarpasa
Egitim Hastanesi, Istanbul, Turkey. Acute renal failure cases associ-
ated with malignant diseases are not commonly seen. We report a case
of acute renal failure with ovarian carcinoma and discuss the other
reports in the literature. A 44-year-old female presented with the
complaints of nausea, abdominal pain and distention on September 5,
1990. Pertinent findings on physical examination were that she was
pale, BP was 110/60 mm Hg, HR was 120 beats per minute, she had
ascites and pretibial edema. On urine analysis, 4.800 mg/liter protein-
uria was found and she was internalized. Pathological examination of
the ascites was reported as "peritonitis carcinomatosa." Pelvic ultra-
sonography and CT scanning revealed a left ovarian mass, 10 x 10 cm
in diameter. When she was admitted to the hospital, blood urea was
found to be 65 mg/dl and creatinine was 2.9 mg/dl. On the fifth day they
were 330 mg/dl and 10.5 mg/dl, respectively. She underwent hemodial-
ysis on the 6th and 11th days along with supportive treatment. Alter the
second hemodialysis the patient developed polyuria and her renal
functions started to return to normal in early November when protein-
uria was at acceptable levels, She underwent abdominal operation in
November 1990, and after total abdominal hysterectomy and bilateral
salpyngooophorectomy, the pathological examination of the mass re-
vealed malignant Brenner tumor of the ovary. Renal biopsy taken
during the operation was reported to be focal tubular necrosis and focal
proliferative glomerulonephritis. The patient is now on chemotherapy,
is being followed monthly and her renal functions are normal.
A retrospective study in children with Henoch-Schonlein vasculitis. H.
Koçak, Z. Durer, A. Balat, Ondokuz Mayis University Medical Fac-
ulty, Department of Pediatric Nephrology, Turkey. Between 1979 and
1990, 85 patients with Henoch-Schonlein vasculitis admitted to Pediat-
ric Nephrology Department of Ondokuz Mayis University Hospital in
Samsun, were analyzed retrospectively. Forty-two of them (49.4%)
were males and 43 (50.6%) females. Their ages ranged from 1.5 to 16
years with a mean age of 9.35 0.39 years. The presenting symptoms
were skin rash (95.3%), abdominal pain (72.9%) and arthralgia, and in
56.3% an acute infection of the upper respiratory tract preceded the
onset of disease. The physical examination of all the patients (100%)
revealed skin rash, characteristic of Henoch-Schonlein vasculitis; 33%
of the children developed arthritis and 72.9% had arthralgia; 25.9%,
edema of the legs; 9.4%, fever; and 5.9% were hypertensive. Gastro-
intestinal bleeding (38.8%), renal involvement (31.8%), hypertension
(5.9%) and central nervous system involvement (1.2%) were the major
complications, and 5.9% of the patients had recurrent attacks. Two of
the patients had a history of abdominal surgery due to acute abdomen
prior to the diagnosis. The course of the disease did not differ in
duration in patients with or without complications. It was also deter-
mined that giving salicylate or dipyridamole to patients did not affect
the recovery phase.
The effects of mixed lymphocyte culture on short and long term success
of renal transplantation. M. Beksaç, K. Dalva, F. GOnenç, I. Dalva, S.
Gartbog/u, N. Batur, S. Renal Transplantation Unit and Immu-
nology Lab, Advanced Specialization, Hospital of Türkiye, Ankara,
Turkey. The selection of a suitable donor and recipient is a leading
parameter that affects the success of renal transplantation. Although
improvement of new immunosuppressive treatment modalities lessened
its effect it still carries importance. Current serological methods are
insufficient in the determination of all major and minor histocompati-
bility antigens. In addition antigenic matches do not always predict
lymphocyte activation and proliferation. The best methods that deter-
mine antigen mismatch, presentation and lymphocyte activation are
dynamic tests such as mixed lymphocyte culture (MLC) or cytotoxic T
lymphocyte tests (CML). In 1988 we started to select living related
donors for renal transplantation using MLC. So far 23 donor-recipient
pairs have been analyzed and 10 transplants have been performed if the
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stimulation index (SI) is below 3. Patient follow-up ranged between 5
and 19 months. The effect of MLC reactivity is summarized in the
Table. As MLC reactive recipients are not transplanted we do not have
data about highly reactive patients. However, even in the range of low
reactivity MLC is important from the aspect of graft survival. Even in
the situation of minor mismatches MLC can be reactive and may
decrease the graft survival.
MLC reactivity (SI) m
0—1 1—2 2—3 3
Class I
mismatches
3 +17
(N=1)
+5(N=l)
— —
2 + 15.5
(N=2)
+ 16.5
(N=2)
1 +8(N=l) 8(N=2) 7(N= 1)
Class II
mismatches
2 +16
(N= 3)
+17
(N= 1)
8
(N=2)
1 +8
(N=1)
+11
(N=2)
7 (N = I)
The effects of hemodialysis on thyroid functions. c. Gakce, 0. Onat,
0. Gokce, E. Arisoy, S. Arisoy, N. Arsian, H. celiker, Y. Ozdemir, N.
lihan, Firat University Hospital, Elazig, Turkey. The endocrine
changes accompanying chronic renal failure (CRF) have recently gen-
erated great interest, with emphasis on alterations in thyroid functions.
Previous workers have demonstrated that an impairment of renal
function is followed by decreases in serum thyroid hormone levels and
the TSH response to TRH, possibly due to decreased hormone-binding
to carrier proteins and pituitary suppression, respectively. Further-
more, a negative correlation between serum creatinine and total T4
levels has been established in acute renal failure, with T4 falling as
creatinine rises and returning to its baseline value if creatinine de-
creases to normal, suggesting a relationship between the adverse effects
on thyroid function encountered in CRF and persistently high levels of
uremic toxins in serum. We argued that hemodialyis (HD) could result
in an improvement in thyroid function by removing some uremic toxins,
and conducted a study on 25 patients with CRF who were maintained
on chronic regular HD and in 20 normal age- and sex-matched controls.
All gave informed consent. Serum total T4 (TT4), free T4 (FT4), total
T3 (TT3) and free T3 (F1'3) as well as TSH levels were determined by
RIA before and after HD in the patients and once in the controls. The
results were statistically evaluated using unpaired or paired Student's
t-test as indicated. The pre-HD TT4, FT4, TF3 and FT3 levels of the
patients were significantly decreased as compared to controls. HD
resulted in statistically relevant increases in all subsets of thyroid
hormones; when the post-HD values of the patients were compared
with those of the controls, TT4, FT4 and TT3 were again found to be
lower but FT3 rose to a level which was not mentionably different from
that of the controls. Thus, HD was associated with favorable changes in
thyroid functions, probably due to augmented hormone binding; since
TSH was increased after HD, a diminution of the suppressive effect of
CRF on pituitary functions by HD could also be possible. The TSH
response to TRH before and after HD must be ascertained to clarify this
observation.
Echocardiographic findings in patients on chronic hemodialysis after a
short-term recombinant human erythropoietin (rHuEPO) therapy. N.
Duman, C. Erol, M. Duranay, B. Erbay, 0. Karatan, Nephroiogy and
Cardiology Department, University of Ankara, Faculty of Medicine,
Ankara, Turkey. Left ventricular hypertropy (LVH) and impaired
myocardial function are frequently seen in patients (pts) on chronic
hemodialysis. Anemia is one of the most important causes of LVH. We
investigated the effects of the correction of anemia with rHuEPO on
LVH and left ventricular function in 14 pts (8 men, 6 women). rHuEPO
(50-150 U/kg three times a week for 34.14 5.14 months) was given to
the pts who were in need of frequent transfusion who had a hematocrit
(Hct) value less than 22%. Echocardiographic examination (M-mode)
was done before the treatment of rHuEPO and when the Hct value
increased more than 30%. The results are shown below.
Baseline Follow-up P value
Hct % 21.42 0.46 33.92 0.63 <0.001
Systolic BP 125.00 2.72 135.00 5.42 >0.05
mm Hg
Diastolic BP 77.50 1.36 87.14 1.45 <0.001
mm Hg
Weight kg 54.21 2.47 55.89 2.38 <0.001
LVEDD cm 5.12 0.20 4.89 0.17 >0.05
LVESD cm 3.67 0.17 3.46 0.13 >0.05
LVEDV ml 140.55 12.55 117.05 13.62 >0.05
IVS cm 1.44 0.06 1.27 0.05 <0.01
LVPWT cm 1.33 0.06 1.21 0.04 <0.05
Mean wall 1.39 0.06 1.24 0.04 <0.01
thickness cm
FS % 30.26 1.24 30.30 0.88 >0.05
LV mass g 368.13 27.59 294.15 26.75 <0.001
Abbreviations are: EDD, end diastolic diameter; ESD, end systolic
diameter; EVD, end diastolic volume; IVS, interventricular septum;
PWT, posterior wall thickness; %FS, fractional shortening.
T + SX, values are mean standard error.
Interventricular septal thickness (IVS), left ventricular posterior wall
and mean wall thickness decreased with rHuEPO therapy. Left ven-
tricular mass also decreased despite the increase of the blood pressure
and patient's weight. Fractional shortening (FS) did not change. These
results showed that LVH significantly decreased with short-term
rHuEPO therapy; however, the improvement of the left ventricular
function could possibly be seen after a long-term follow-up.
Renin-angiotensin-aldosterone system in the pathogenesis of erythro-
poietin related hypertension. T. Arinsoy, N. Arik, C. Sungur, B. Erbas,
Z. Koray, U. Yasavul, Turgan, . cgk,-, Hacettepe University
School of Medicine, Departments of Nephroiogy and Nuclear Medi-
cine, Turkey. One of the adverse effects of recombinant human eryth-
ropoietin (rHuEPO) which is used in the treatment of renal anemia is
hypertension. Approximately one third of hemodialysis patients treated
with rHuEPO will experience either an aggravation of pre-existing
hypertension or will develop de novo hypertension. Alterations in levels
of renin-angiotensin-aldosterone have been suggested in the pathogen-
esis of rHuEPO related hypertension. This study was designed to
investigate the effect of rHuEPO treatment on plasma renin activity
(PRA) and aldosterone levels in patients who were on regular hemodi-
alysis. The study group included 21 subjects (14 men, 7 women).
Hemoglobin (Hb), Hematocrit (Hct), plasma renin activity (PRA) and
aldosterone studies were performed at the beginning and sixth week of
rHuEPO treatment. Blood pressure and body weight of the patients
were measured before and after therapy. The results are as follows;
Before
treatment
After
treatment
P
value
Hb g/di 8.6 10.3 <0.05
Hct % 26.2 30.2 <0.05
Systolic BP mm Hg 123.8 136.9 <0.05
Diastolic BP mm Hg 79.7 85.0 <0.05
PRA ng/mi/hr 4.6 5.6 >0.05
Aldosterone pg/mi 340.6 301.4 >0.05
Body weight kg 64.5 64.3 >0.05
The results show that in spite of the fact that significant increases in
mean Hb, Hct and systolic and diastolic blood pressure readings were
observed, mean PRA and aldosterone levels remained unchanged. So,
we conclude that renin-angiotensin-aldosterone system may have no
role in the pathogenesis of rHuEPO related hypertension.
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Deferoxasnine infusion test in the diagnosis of aluminum related
osteodystrophy in children. N. Beffba, 0. SOylemezotlu, U. Saatçi, A.
BakkaloIu,A. 1imer, Hacettepe Children Hospital Pediatric Nephrol-
ogy Unit, Ankara, Turkey. Aluminum accumulation as a patential toxic
risk in patients, especially in children with chronic renal insufficiency is
a well known phenomenon. The chelating agent deferoxamine (DFO)
can mobilize aluminum from tissues, and its administration may facili-
tate the removal of aluminum by peritoneal or hemodialysis. We
evaluated the effect of a standard dose 40 mg/kg deferoxamine on
plasma concentrations in 17 pediatric patients on hemodialysis. Base-
line serum aluminum concentrations were greater than 200 jig/liter in all
except one patient, and ten of them had the clinical symptoms of
metabolic bone disease. After 4 hours of hemodialysis session the
increment was 261 + 294 jig/liter, and this was explained by high
dialysate aluminum concentration, which was greater than 10 jig/liter.
After administration of deferoxamine the increase in serum aluminum
concentrations was 785 + 515 and 897 + 418, 381 + 355 jig/liter at 24
and 40 hours, respectively. We couldn't find a significant correlation
between serum PTH and increment in aluminum concentrations. Be-
cause the increase in serum aluminum concentrations were greater than
300 jig/liter and the baseline serum aluminum concentrations were
greater than 200 jig/liter, we thought that the DFO infusion test is a
noninvasive method in excluding the diagnosis of aluminum related
osteodystrophy, and DFO treatment must take place in treating alumi-
num toxicity in dialysis patients.
Peritoneal hemosiderosis In pediatric patients with nephrogenic ascites.
N. Beyba, 0. Soylemezoglu, U. Saalçi, A. Bakkaloglu, S. Arslan, S.
Gogu, R. Topalolu, Hacettepe Children Hospital Pediatric Nephrol-
ogy Unit, Ankara, Turkey. Nephrogenic ascites is a complex diagnostic
problem with poorly understood pathophysiology in hemodialysis pa-
tients. We report four pediatric patients investigated between 1986 and
1990. All the patients were treated with maintenance hemodialysis and
two patients developed ascites six months after starting hemodialysis,
All of them had previous peritoneal dialysis treatment and blood
transfusions. Each patient were carefully reviewed for factors poten-
tially relevant to ascites. Measurements were sought specifically indi-
cating the presence or absence of congestive heart failure, pericardial
disease, liver disease, fluid overload, and peritoneal disease. Laparos-
copy which was utilized in all patients led to a specific diagnosis of
hemosiderosis in the peritoneum and liver. In one patient lymph node
biopsy also showed hemosiderosis. Serum ferritin levels were ex-
tremely high. We believe that iron deposition played a role in changing
the permeability of the peritoneum and presumed it to be a pathogenetic
factor in nephrogenic ascites.
Noninvasive monitoring of renal allograft functions. 1, Dalva, K.
Dalva, F. Akbay, Z. Gtinq, S. Ayaz, M. Beksaç, F. Gonenç, S. ctth
Renal Transplantation Unit, Immunology and Hematology Lab, Ad-
vanced Specialization Hospiial of Turkiye, Ankara, Turkey. In this
study we investigated 28 living-donor and 2 cadaveric renal transplan-
tations which had been performed by our transplantation team. Thirty
patients were studied for 20 months following allografting. All patients
were on triple immunosupression therapy (CsA+Aza+Pred). We mea-
sured urinary beta2 microglobulin (/32m), alpha I microglobulin (a1m),
retinol binding protein (RBP), N-acetyl-glucoseaminindase (NAG) and
serum fl2m, a1m, RBP, C-reactive protein (CRP) according to specific
protocol and compared with BUN, creatinine and level of CsA in serum
in order to assess sensitivity and their diagnosis value. a1m was 62.09
14,5 mg/liter in stable patients and 123.1 1 mg/liter in rejections. We
found that a1m was more sensitive than creatinine in prediction of GFR
(P C 0.05). Urinary RBP was 0.56 0.02 mg/liter in stable patients and
17.80 2.58 mg/liter in rejection, and was more reliable than urinary
132m (1.1 0.2 mg/liter and 3.2 1.3 mg/liter, respectively) and NAG
(1.52 0.6 U/mmol creatinine and 3.04 2.30, respectively) in
assessing proximal tubular damage (P C 0.50). Serum f32m level was
high 3.55 0.88 days before rejection started. Serum f32m and urinary
/32m and urinary RBP have diagnostic value in differentiation of CsA
nephrotoxicity and rejection. In conclusion, serum 2m, urinary /32m,
urinary RBP, serum a1m have prognostic value in distinguishing
rejection and CsA nephrotoxicity while monitoring renal allograft
functions.
Serum
crcatinine
Serum
/32m
Urinary
thm
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Stable
Rejection
<1.8
1.23 0.9
4.51 1.09
1.2—2.9
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3.2 1.3
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Hemodialysis and coagulation inhibitors. N. Arik. 0. Ozdemir, T.
Akpolat, T. Arinsoy, 0. Ozcebe, S. Ddndar, U. Yasavul, Turgan, $.
Hacettepe University School of Medicine Departments of
Nephrology and Hematology, Turkey. It has been shown that protein C
activity increases acutely during hemodialysis. The underlying mecha-
nism, however, was unclear and the presence of an unknown dialyzable
inhibitor of protein C in uremic plasma has been speculated on before.
In order to clarify the role of protein C inhibitors in the genesis of
protein C changes during hemodialysis, we studied the two well-known
protein C inhibitors, plasminogen activator inhibitor-3 (PAI-3) and
alpha1-antitrypsin(a1-AT) in relation to protein C activity (PCA) before
and after hemodialysis in uremic patients on regular dialysis. Eighteen
healthy controls and 20 patients with end-stage renal failure were
studied. The mean values of protein C activity, PAI-3, and a1-AT levels
in 20 patients and 18 controls are presented below.
Before
hemodialysis
After
hemodialysis Control
PCA % 60.5 115.6 107.4
PAI-3 % 84.2 131.0 120.5
a,-ATmg/dl 217.3 238.5 207.4
Mean PCA before dialysis was found to be lower in the uremic group
than in the control group (P C 0.05) and increased significantly after
dialysis compared with predialysis values (P C 0.02). Hemodialysis
induced statistically significant increases in PAI-3 activity, as well (P C
0,02). Observed significant increase in mean a1-antitrypsin level (P C
0.05) was considered to be due to volume contraction caused by
hemodialysis procedure itself, because postdialysis cr1-AT levels cor-
rected for the changes in Hct were comparable with predialysis levels
(F> 0.05). In the present study, it is shown, as previously reported,
that PCA is low in uremic patients and a single hemodialysis session
restores this defect. In spite of the fact that we did not demonstrate any
decrease in protein C inhibitors, marked increase in PCA was observed
during hemodialysis treatment, namely, alterations in protein C inhib-
itors do not account for the restoration of PCA during hemodialysis.
Therefore, we conclude that the determined increases in PCA in the
course of hemodialysis should be due to the presence of a hitherto
unknown dialyzable inhibitor(s) of protein C in uremic plasma other
than the known protein C inhibitors presently described.
The effects of 1,25 dihydroxyvitamin D, on cellular hnmunity in chronic
hemodialysis patients. 0. Alpdojan, S. Ozgun, Ozener, F. Akolu, T.
Akoglu, Department of Internal Medicine, Marmara University Medi-
cal School, Turkey. Recent studies have shown that there are decreases
in the total number of T lymphocytes, CD4 lymphocytes, CD4/CD8
ratio, interleukin-2 release and inefficient mitogen-induced lymphocyte
blastic transformation in chronic renal failure patients on hemodialysis.
It is also known that 1,25 dihydroxycholecalciferol (active D3) has an
immunoregulatory role. In this study the alterations of the mitogen-
induced lymphocyte response using PHA (phytohemagglutunin) and
Con A (concanavalin A) as a mitogen was investigated in nine patients
under a chronic hemodialysis program who received 1,25 dihydroxyvi-
tamin D3 (0.5 jig/day) orally for a 4-6 week period. Additionally at the
end of the treatment interferon was administered to the lymphocyte
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culture medium and the resulting changes in the lymphocyte prolifera-
tion were observed. Healthy individuals also were included as a control
group.
Stimulation indices
1,25 (OH)2 D3
Pretreatment Posttreatment Interferon Control
PHA 15.4 12.4 36.8 18.8 26.3 18.0 39.8 30.2
Con A 7.2 2.3 18.5 11.8 13.4 11.6 20.0 13.9
Our results show that vitamin D treatment significantly increases
stimulation indices which were provided by PHA and Con A, and brings
them to the control level. Administration of interferon to the medium
demonstrated no significant changes. In conclusion the use of oral 1,25
dihydroxycholecalciferol improves mitogen-induced lymphocyte prolif-
eration in chronic renal patients.
The prevalance of proteinuria, hematuria and hypertension in healthy
primary school children in Trabzon region. H. Mocan, A. Okten, V.
Gedik, E. Erduran, P. Akyazici, Karadeniz Technical University,
Turkey. In this study 1100 healthy primary school children (516 girls,
584 boys) aged between 7 and 12 years were evaluated for the
prevalence of asymptomatic proteinuria and hypertension. Physical
examination findings and basic laboratory tests were within normal
limits in these children. Pj-otejnuria was found in 1.81% of the children,
being 2.71% in girls and 1.03% in boys. The prevalance of hematuria
was 3.45% in all children, being 4.84% in girls and 2.23% in boys. High
blood pressure measurements were recorded in 2.18% of children,
being 2.90% in girls and 1.54% in boys. Children who showed patho-
logical findings were evaluated in the pediatric renal department as
outpatients.
Effect of erythropoietin treatment on antithrombin III, fibrinogen and
protein C levels. T. Arinsoy, 0. Ozdemir, N. Arik, C. Sungur, 0.
Ozcebe, S. Dundar, U. Yasavul, Turgan, . cgk, S. Kirazli,
Hacettepe University Medical School, Depts of Nephrology and Hae-
matology, Ankara, Turkey. One of the adverse effects of recombinant
human erythropoietin (rHuEPO), which is used in the treatment of
anemia of chronic renal failure, is increased tendency to thrombosis.
Alterations in the levels of coagulation inhibitors have been suggested
in the pathogenesis of rHuEPO-related thrombosis. This study was
planned in order to investigate the effect of rHuEPO treatment on
antithrombin III (AT-Ill), fibrinogen and protein C (PC) levels, in
patients with chronic renal failure undergoing regular hemodialysis
treatment. The study group included 34 subjects (23 men, 11 women).
Hemoglobulin (Hb), Hematocrit (Hct), fibrinogen, AT-ILL and PC
studies were performed at the beginning and sixth week of rHuEPO
treatment.
Pretreatment
At sixth
week P value
Hb g/dl 8.35 10.32 <0.0001
Hct % 25.61 30.50 <0.0001
PC % 71.2 96.3 <0.01
Fibrinogen mg/dl 370.7 312.7 <0.01
AT-Ill mg/dl 29.03 25.32 <0.001
While Hb, Hct, and PC levels demonstrated significant increase,
fibnnogen and AT-Ill levels declined after six weeks of treatment with
rHuEPO. It is concluded that hypoantithrombinemia may contribute to
increased tendency to thrombosis.
Application of RFLP method on LILA typing. 0. Terzloglu, S. Mir, A.
Ozaip, University of Dokuz Eylul, Faculty of Medicine, Medical Biol-
ogy-Genetics, Inciralti, and Universite of Ege, Faculty of Medicine,
Childhood Health and Sickness, Bornova, Izmir, Turkey. Rejection
reactions in tissue transfer between individuals of the same species are
very important problems. The system consists of several complex
molecules called major histocompatibility complex (MHC). Class II
antigens are one main group of human leukocyte antigens (HLA). They
have very critical functions in triggering mechanisms related to human
tissue transfer immune reactions. The antigens are coded by polymor-
phic genetic sequences, and are determined by different arrangements
of DR, DQ and DP in the DNA level. Several different tissue types are
identified by the mechanisms. These different HLA types are widely
investigated by serological and cellular methods. But the methods are
insufficient to identify all subtypes as a result of high polymorphism.
Restriction fragment length polymorphism (RFLP) has been established
to detect specific DNA sequences during 1980. The same protocols
were applied in HLA typing. The results obtained by RFLP and
serology were compared with standard tables prepared in the 1989
International HLA Workshop and European Transplantation Working
Group. DR beta eDNA was obtained from pRTV1 bacterial plasmid by
Pstl endonuclease digestion. The eDNA were used as a probe after
labelling by radioactive phosphorus. Ten micrograms of high grade total
human DNA were extracted from serologically tested human lympho-
cytes. The DNA was digested with Tag 1 restriction endonuclease. The
digest was subjected to electrophorese on 0.7% agarose gel, transferred
hybond membrane by Southern blotting and hybridized with labelled
probe. After autoradiography of the membrane, the results were
valuated by comparing with standards, and subtypes were observed.
Sexual maturation in children with chronic renal failure. M. Ekim, N.
Turner, G. Ocal, F. Yalcinkaya, C. Ensari, Ankara University Faculty
of Medicine, Pediatric Nephrology Unit, Ankara, Turkey. This study
was undertaken to evaluate the onset of puberty, to investigate the
hypothalamic-pituitary-gonadal axis and other factors that may cause
delayed puberty in children with chronic renal failure (CRF). In this
preliminary report, the results of 10 patients (5 girls and 5 boys) with
CRF were presented. Mean age was found to be 15.5 2.18 years,
somatic development was determined by using height, height standard
deviation score (HSDS), growth velocity (GV), growth velocity stan-
dard deviation score (GVSDS) and bone age with the standards of
Greulich and Pyle. Pubertal development was evaluated according to
Tanner-Marshall criteria and integrated estrogen exposure in girls was
determined by using an estrogen scoring system. Basal estradiol,
testosterone, LH and FSH levels, pulsatile secretion of gonadotropins
during sleep and the response of gonadotropins to LH-RH stimulation
were used to examine the hypothalamic-pituitary-gonadal axis function.
Mean height of the patients was found to be 139.85 + 3.91 cm and all of
them were under third percentile. HSDS was —3.74 + 0.61, GV was
3.85 + 1.24cm/year, GVSDSwas —1.53 + 0.91 andboneagewasfound
11.8 + 0.79 years. In girls mean age was 16.4 + 1.28 years and mean
estrogen score was found to be 11.8 + 5.63. While all of them were
expected to be in stage 5 sexual maturation only one patient was found
in stage 5. In boys mean age was 14.6 + 0.29 years. The volume of
testis, the length and circumference of penis were found significantly
retarded when compared the same age control group. Bone age showed
a close correlation with sexual development but both were found
retarded according to the chronologic age in all patients. Hypothalamic-
pituitary-gonadal axis of the patients was appropriate to the chronologic
age. Basal LH and FSH, the peak amplitude of LH and FSH during
sleep and LH-FSH response to LH-RH stimulation in girls were: 9.52
3.27 sIU/ml, 3.92 1.59 jIU/ml, 70.56 59.73 piU/ml, 16.03 7.54
1aIU/ml, 141.66 22.62 .tIU/ml 19.83 3.86 idU/ml, respectively. The
same parameters in boys were 6.34 0.86dU/ml, 4.22 1.17dU/ml,
10.82 0.57 j.tIU/ml, 4.15 2.39 tIU/ml, 46.50 2.95 JU/m1, 8.05
2.97 dU/ml respectively. Serum estradiol levels in girls (mean 18.42
0.13 pg/mI) and serum testesterone levels in boys (mean 1.25 0.40
ng/ml) were in accordance to the pubertal stage and bone age, but both
were low according to the chronologic age. The results of our study
showed that hypothalamic-pituitary axis was normal in children with
CRF. Sexual maturation showed a close correlation with somatic
development.
General evaluation of our cadaver kidney donors. S. Yamaner, U.
Eldegez, M. carin, M. Sever, A.E. Aydin, University of Istanbul,
Faculty of Medicine, Department of General Surgery, Transplantation
Unit, and Department of Internal Medicine, Istanbul, Turkey. In this
study, we evaluated 67 cadaver kidney donors who were nephrecto-
mized, after their deaths from November 1987 to February 1991. Of
these 67 donors, 50 were males and 17 females. The youngest donor was
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a 7 month old and the eldest was 61 years old (mean 19.1). The cause of
death was traffic accidents in 38, falls in 22, shotgun injury in one,
neurologic disorders in 4 and other medical diseases in 2 donors. Our
Emergency Surgery Unit is our principal donor source. (61 donors).
Cooperation with other clinics has provided us with another 6 donors
and this cooperation will help us expand our organ sources for trans-
plantation.
Diagnostic value of serum ferritin levels in patients undergoing regular
hemodialysis treatment. K. Yamaç, I?. Haznedar, S. Sindel, H. Aikim,
0. Sucak, E. Hasano gin. Iron deficiency has become a frequent
complication of patients undergoing regular hemodialysis treatment. It
was the aim of this study to determine the diagnostic value of serum
ferritin levels in patients with renal failure and anemia of iron defi-
ciency. The study was carried out in 20 patients under chronic hcmo-
dialysis program. Diagnosis of iron deficiency was established with the
examination of bone marrow iron stores, In 9 cases stainable iron was
absent in marrow. Serum ferritin levels of these 9 subjects were either
normal or increased (189 213 zg/liter). Serum iron levels were
between 64 and 96 sg/dl (79.3 11) with a decreased level only in one
case, total iron binding capacity (TIBC) between 254 and 385 tg/dl (313
38), and transferrin saturation (TS) was 25.5 4%. The sensitivity,
specificity, predictive value and accuracy of serum ferritin levels were
0%, 100%, 0% and 55%, respectively. Correlations were made between
age, sex, serum iron, TIBC, TS and serum ferritin in all patients. No
significant correlations were found between serum ferritin and these
other variables. Serum ferritin, iron, TIBC and TS are not helpful for
diagnosis of the anemia of iron deficiency in patients with chronic renal
failure. Although the estimation of serum ferritin is useful in patients
with uncomplicated iron deficiency; frequent incidence of chronic
infection and infiamation of patients with renal failure challenges the
diagnostic value of serum ferritin measurements. In such circum-
stances, examination of stainable marrow iron is still the most reliable
diagnostic tool.
The changes of serum thyroid hormone levels in end-stage renal failure
and effect of hemodialysis on these changes. M. Koruk, A. San, HZ.
Tonbul, E. Bakan, Ataturk University, Medical School, Nephrology
Department, Erzurum, Turkey. In our study, we aimed to establish the
alterations caused by uremia in serum thyroid hormone levels and to
ascertain how hemodialysis effects these alterations. This study in-
cluded 20 non-hemodialysis patients with CRF (Group 1), 20 patients
with CRF on a regular hemodialysis program (Group II), and 20
volunteer healthy subjects. All patients were clinically euthyroid. The
serum TT4, TT3, FT4, FT3, and TSH levels of control and patients
were measured. The results determined in control and patient groups
and statistical evaluation are seen in Table.
Table. All data obtained in patients and control groups and statistical
evaluation.
Group I
(N= 20)
Group II
(N= 20)
Controls
(N = 20)
'fl'4 p.g/dl
1T3 ng/dl
3.96 2.4l'
56.73 35.l0a
5.61 2.33
68.16 39.60
6.76 l.41c
137.24 3l.6l
FI'4 pg/mi
FF3 pg/m/
TSH yJU/mi
7,40 3.79°
3.38 4.49
2.26 207a,d
8.08 3.32
3.64 4.16
0.79 0.63
15.76 557d
8.55 S.57'
0.54 0,13c
a P < 0.001 according to controls
b.c p C 0.05 and P> 0.05, respectively, according to Group II
d P C 0.001 according to both Group I and II
In group I, there was uo correlation between the results obtained and
GFR (P c 0.05). It was concluded that had no effect on hemodialysis on
the serum thyroid hormone abnormalities in uremia, but that single
hemodialysis sessions caused an acute rise in serum fl4, TT3, FF3
levels. The findings suggest that the decrease in serum thyroid hormone
levels of patients with uremia is probably a biological adaptation
mechanism. Further, more detailed studies are needed to understand
thyroid hormone abnormalities whether in peripheral metabolism or the
pituitary-thyroid axis.
Results of the Turkish multi center study in rHuEPO therapy compared
to the European study. 0. Oozma, SSKlstanbu/Hastanesi, Cerrahpaca
Tip Fakultesi, SSK Ankara Difkapi Hastanesi, I. U. Tip Fakultesi, SSK
Gôztepe Hastanesi, Bostanci Organ Nakli ye Yanik Tedavi Vakfi
Hastanesi, Ankara Organ Nakii ye Yanik Tedavi Vakfi Hastanesi, SSK
Tepecik Hastanesi, I. U. Tip Faktiltesi cocuk Nefrolojisi, Hacettepe U,
Tip Fakd/tesi cocuk Nefrolojisi, Turkey. An open, nonrandomized
multicenter study was performed in 10 Turkish nephrology centers, 8
adult centers and 2 pediatrics centers at Ankara, Istanbul and Izmir.
The objective of the study was to evaluate the effectiveness and safety
of rHuEpo (EPREX) in the treatment of anemia-associated end-stage
renal disease. A total of 53 patients were studied for 16 weeks, 25 males
and 28 females with a median age of 38 years (range from 20 to 65
years), and for children from 10 to 15 years age. The median baseline
hemoglobin at the time of entrance into the study was 6.6 g/dl. The
rHuEPO dosage was 50 U/kg given three times/week for 4 weeks, and
25 U/kg three times/week for children. The dosage was adjusted on the
basis of the hemoglobin response, and adjustments were made every 4
weeks by adding 25 U/kg to a maximum dosage of 200 U/kg three
times/week. At the end of the study 98% of the patients were classified
as responders. The most significant side effects related to rHuEPO
therapy were: hypertension in 26%, increase serum creatinine in 18%,
hyperkaliemia in 10%, and one patient developed seizure. The following
table compares the Turkish study to the European multicenter study
sponsored by Cilag in 6 nephrology centers.
Response to Hyper- Increased Hyper-
rHuEPO tension Seizure creatinine kaliemia
European 92% 20% N = 1 — —
study
Turkish 98% 26% N = 1 18% 10%
study
In conclusion, the results of the Turkish multicenter study were similar
to the European study, in that in both rHuEPO effectively reversed
anemia in all dialysis patients with sufficient iron stores. Effects on
increase in blood pressure, serum creatinine and potassium can be
avoided or minimized by modifying the antihypertensive drug and the
patients' dry weight, and by restricting some dietary habits. On the
other hand, there was no change in WBC count and thrombocytes in the
Turkish results.
Effect of hemodialysis-induced hypoxcmia on activation of llhrinolytic
system. 0. Ozdemir, N. Arik, 0. OzcebeL S. Dtindar, T. Arinsoy, C.
Sungur, Turgan, U. Yasavu/, S. S. Kirazli, Hacettepe
University School of Medicine Departments of Nephro/ogy, Hematol-
ogy and Chest Disease, Turkey. It is well known that hemodialysis
(MD) causes a rise in plasma tissue-type plasminogen activator (t-PA).
Although there have been several suggested mechanisms responsible
for this effect of HD, the precise cause has not been well understood
yet. Another complication of MD is hypoxemia which is commonly
observed during the first hour of the session. The aim of this study was
to investigate the relationship between dialysis hypoxemia and HD-
induced t-PA changes during the first two hours of HD. HD caused a
significant increase in plasma t-PA antigen levels. When individual t-PA
profiles against time were examined, two patterns were observed.
While ten subjects (56%) experienced minimal or no increase, t-PA
antigen level of those remaining began to rise at 30 minutes and
continued at that level up to 90 minutes, when the last samples were
drawn. The courses of p02 were also different; while the former group
had early-onset and short-term hypoxemia, the latter had late-onset and
prolonged hypoxemia. The amount of increase of t-PA antigen and the
amount of decrease in p02 were correlated at 60 and 90 minutes of the
MD session. Thus, it is concluded that dialysis hypoxemia may contrib-
ute to HD-induced rise in plasma t-PA levels. Further studies compar-
ing different dialysates and dialyzer membranes are required to confirm
this hypothesis.
Evaluation of survival of auto-cross-match positive renal transplants.
N.M. Hamamizade, 0. SOnmez, U. Akar, A. Sinaz, N. Harman, M.
carin, istanbul Tip Faktiltesi Tibbi Biyo/oji Anabi/im Dali, Turkey. The
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third requirement after blood and tissue group compatibility in renal
transplantation is a negative cross-match. In some cases, though the
first two requirements are fulfilled, a positive cross-match prohibits the
transplantation. This positivity is due to 1gM and IgG type antibodies.
It is widely accepted that 1gM antibodies do not affect the survival of
the allograft. In this study we tried to evaluate our results. We analyzed
venous blood samples from 23 kidney recipients and their donors.
Lymphocytes were isolated from these blood samples and were mixed
with recipient sera on Terasaki plaques. We used here the lymphocytes
from the donors to show the auto-antibodies. Allo-antibody typing was
achieved using DTT (Dithiothreitol) and adding trypan blue to the
antigen-antibody complex, and evaluating the result with invert-micro-
scope. Twenty-three of our cases with last stage renal failure who
received a kidney from a living donor had a positive auto-cross-match
and 1gM allo-antibodies. These cases were included in this study. No
explanation and no death was observed in this group since May 1989.
Three patients had transient rejection attacks in the first weeks. In
conclusion, we observed that a positive auto-cross-match and 1gM type
allo-antibodies do not influence recipient and graft survival negatively.
Effects of extracorporeal shock wave lithotripsy (ESWL) on renal
function in children. E. Hasanoglu, N. Buyan, I. Bozkirli, F. Demirel,
U. Karaolan, Gazi University, Faculty of Medicine, Department of
Pediatrics and Urology, Turkey. ESWL has been performed with the
increasing frequency in the treatment of childhood urinary tract stone
disease (UTSD). We carried out the following study to examine the
effects of that therapy on renal function. We studied 40 children aged 2
to 14 years who underwent ESWL for the treatment of UTSD. We
studied tubular and glomerular function of these patients with UTSD
before and three months after completion of ESWL. We determined
urinalysis, urine culture, urine osmolarity, protein, calcium, creatinine,
phosphate, sodium, potassium, uric acid concentrations in 24-hour
urine and BUN, creatinine, calcium, phosphate, alkaline phosphatase
uric acid, sodium, potassium levels in the serum of our patients.
Additionally, we measured pre- and post-ESWL I2 microglobulin levels
and pre-ESWL amino acid in urine. We calculated; GFR, FENa, FEK,
TmP/GFR, 24-hour protein (mg/m2/st), calcium (mg/kg) excretions
according to our results. We found no statistical differences between
pre- and post-ESWL results. We concluded that ESWL is a safe
procedure in children since it has no long-term effect on renal function.
The etiology of amyloid nephrosis in East Anatolia. A. San, H.Z.
Tonbul, G. Akcay, 1'. Selcuk, M.A, cftcioglu, The Departments of
Nephrology, Internal Diseases and Pathology, The Faculty of Medi-
cine, Atatürk University, Erzurum, Turkey. The etiology and clinical
characteristics of amyloid nephrosis (AN) were researched in 14
patients with nephrotic syndrome (NS) diagnosed as AN with renal
biopsy in the years between 1985 and 1990 in our clinic. Ten cases were
men (71%), 4 cases were female (29%) and their ages were between 14
and 57 (31 13). In all cases, amyloidosis was secondary (reactive) and
the causes of amyloidosis were FMF (57%), pulmonary tuberculosis
(21%) and other (21%), respectively. In patients creatinine clearance
was 15 to 120 ml/min. (70 45), serum albumin concentration was 1.5
to 2.4 g/dL. (1.9 0.9), 24-hour urine protein levels were 2.9 to 14 (6
3) g. In five cases, moderate renal failures were present and in 43
percent of cases, hypotension was determined. Conclusion: the cases of
AN generally can be diagnosed after clinically establishing NS. FMF
takes place in the first order in the etiology AN in our region. Therefore,
the cases with unexplained proteinuria should be investigated with
respect to amyloidosis, and the treatment toward the etiologic factor
should be initiated earlier.
Effects of captopril administration on blood pressure, proteinuria and
kidney functions in patients with diabetic nephropathy. N. Kocak, S.
Bozfakioblu, M$. Sever, S.T. Ecder, N. Aysuna, E. Ozdogan, . Tuna,
E. Ark, Istanbul Medical Faculty, Department of Nephrology, istan-
bul, Turkey. Effects of captopril administration on blood pressure,
proteinuria and kidney function in patients with diabetic nephropathy
were investigated for 5 days. Twelve patients with type I and type II
diabetes mellitus were analyzed. The drug, at a dose of 100 mg/day,
reduced arterial blood pressure significantly. Plasma renin activity and
aldosterone levels were found to be decreased after converting enzyme
inhibition. Urinary Na and K excretion decreased in 6 and 5 patients,
respectively. The excretion of Na was variable in 5 patients and K in 6
patients. Only one patient's daily Na and K excretion increased after
captopril administration. Urinary protein excretion decreased in all of
the patients. Creatinine clearance reduced significantly. Seven healthy
volunteers were taken as control cases. Five days after captopril
administration at the same dose, arterial blood pressure decreased less
significantly. Plasma renin activity and aldosterone levels increased in
control cases. Urinary Na increased in 5 cases and showed variable
levels in 2 cases, whereas urinary K excretion increased in 3 cases and
showed variation in 4 cases. In one of the control cases, transient trace
proteinuria was noted. No significant changes in creatinine clearance
were observed. The findings were explained on the basis of direct
stimulation of aldosterone release from the adrenal glands, direct
tubular effects of captopril and improved systemic and glomerular
hypertension.
Effect of verapamil against cyclosporine induced nephrotoxicity. H.
Bilge!, S. Kilicturgay, L. Tatlikazan, T. Yilmazlar, T. Avsar, T. Er-
bengi, Departments of Surgery and Pathology, University of Uludag,
Bursa and Department of Histology, University of Istanbul, Istanbul,
Turkey. Introduction of cyclosponn A (CsA) in clinical transplantation
in 1978 by Caine et al was a major breakthrough in transplantation
medicine. Unfortunately this powerful immunosuppressive drug was
nephrotoxic. This side effect of CsA is more pronounced with kidneys
subjected to long, cold ischemia time. Some preventive measures were
proposed, such as keeping cold ischemia time as short as possible,
withdrawal of CsA during the first two weeks immediately after
transplantation, avoiding other nephrotoxic drugs and using drugs to
prevent CsA induced nephrotoxicity. The aim of this study was to
examine the effect of calcium blockage with verapamil in preventing
CsA induced nephrotoxicity in the rat. A total of 204 male Swiss Albino
rats between 200 and 250 g were used. Rats were assigned to four
groups. The rats were anesthetised with 50 mg/kg sodium pentothal
intraperitoneally. Unilateral nephrectomy was carried out and then
renal artery was occluded for 40 minutes with an atraumatic microvas-
cular clamp, and after then the clamp was removed. Treatment of CsA
and verapamil started one hour before the surgery and continued for 14
days. Groups were as follows: Group 1, no treatment; Group 2,
verapamil 5 mg/kg was given subcutaneously twice a day; Group 3, CsA
(Sandimmune, Sandoz) 40 mg/kg was given orally each day; Group 4,
verapamil and CsA were given in doses as indicated in groups 2 and 3.
Following the surgery, animals were sacrified on days 2, 4, 6, 9, and 14
with each study group. Blood samples for serum creatinine, urea,
potassium and CsA plasma level were taken. Then the kidney was
excised and processed for light and electron microscopy. CsA plasma
level was measured by polyclonal RIA-kit (Sandoz). The data were
subjected to analysis of variand and Student's (-test. In the light
microscopy all of the CsA treated rats (Group 3 and 4) showed fine
vacuolization, cytoplasmic inclusion bodies and tubular cell atrophy in
the proximal tubulus. Also interstitial edema and early signs of fibrosis
were detected on day 14. Electron microscopy: all of the CsA treated
rats showed increased numbers of lysosomes in tubular cells and
isometric vacuolization in proximal tubular epithelium. Endothelial cell
swelling and increased kollage around the capillaries were also noted on
day 14. Ultrastructural changes were more pronounced in group 3 than
in group 4. CsA treated rats had significantly higher serum Cr levels
than group 1 and 2. The mean Cr and BUN levels were significantly
different between group 3 and 4 on days 2, 4, 6, 9, 14, except urea levels
on days 2 and 6. Our results revealed beneficial effect of verapamil on
CsA induced nephrotoxicity.
